JAMA子刊:非侵入性脑刺激干预对精神分裂症阴性症状的影响

2022-06-29 MedSci原创 MedSci原创

左背外侧前额叶皮层的兴奋性NIBS方案与消极症状严重程度的明显大的改善有关。

精神分裂症阴性症状对患者的功能结果和生活质量有不利的影响,而且很少有治疗方案被认为对这一症状层面有效。研究表明,无创脑刺激(NIBS)干预措施可能对治疗消极症状有效。然而,不同的NIBS方案对缓解消极症状的疗效比较仍不清楚。

为了比较不同NIBS干预措施对治疗消极症状的疗效和可接受性,来自我国台湾的学者开展了一项meta分析。对ClinicalKey、Cochrane CENTRAL、Embase、ProQuest、PubMed、ScienceDirect、ClinicalTrials.gov和Web of Science等电子数据库进行系统性检索。

该网络荟萃分析以评估评价重复经颅磁刺激(rTMS)、θ-突发刺激、经颅随机噪声刺激、经皮迷走神经刺激和经颅直流电刺激对精神分裂症阴性症状疗效的试验结果的汇总。研究对精神分裂症患者进行NIBS干预的随机临床试验(RCTs)被包括在内。

结果涉及2211名参与者(平均[范围]年龄,38.7[24.0-57.0]岁;女性患者的平均[范围]比例,30.6%[0%-70.0%])的48项RCT被纳入。与假对照干预相比,兴奋性NIBS策略(差异[SMD]:高清晰度经颅随机噪声刺激,-2.19[95%CI,-3.36至-1.02];间歇性θ爆发刺激,-1.32[95%CI,-1.88至-0.76];正极经颅直接电流刺激,-1.28[95%CI,-2.55至-0. 02];高频经颅磁刺激,-0.43[95%CI,-0.68至-0.18];极端高频经颅磁刺激,-0.45[95%CI,-0.79至-0.12])在左背外侧前额叶皮层上进行或不进行大脑对侧区域的其他抑制性刺激方案,与消极症状的明显减少有关。各组之间的可接受性没有明显差异。

综上,在这个网络荟萃分析中,左背外侧前额叶皮层的兴奋性NIBS方案与消极症状严重程度的明显大的改善有关。

 

参考文献:

Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia: A Systematic Review and Network Meta-analysis . JAMA Psychiatry. Published online June 22, 2022. doi:10.1001/jamapsychiatry.2022.1513

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
    2022-06-27 amyloid
  5. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
    2022-06-25 肿瘤克星

    JAMA上文章都是顶级的,谢谢梅斯及时上新

    0

相关资讯

JAMA子刊:炎症可能通过激活小胶质细胞和/或星形细胞功能障碍导致大脑结构的变化

由基因决定的IL-6与大脑结构有关,并可能影响发育期神经精神疾病(包括精神分裂症和自闭症)所涉及的区域。

Human Brain Mapping:首发未治疗精神分裂症患者伴听觉言语幻觉的颞叶、额叶皮质和丘脑存在半球间和半球内功能连接动态学异常

精神分裂症AVHs患者半球间和半球内dFCD的异常时间变异性主要集中在作为听觉和语言通路关键组成部分的颞叶、额叶皮质和丘脑。

JAHA:精神分裂症、分裂情感障碍或双相情感障碍患者的心血管风险

近日,心血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员旨在比较伴有和不伴有严重精神疾病(SMI;双相情感障碍、精神分裂症或分裂情感障碍)患者估计的10年和30年心血管风险。

Lancet Psychiatry:50年的研究数据——精神分裂症患者教育程度正在改善!

精神分裂症患者在教育程度方面持续面临不平等

AP&T:精神分裂症和新发炎症性肠病的风险

精神分裂症是一种思想方式、语言观点、情绪、自我认知和行为表现能力出现异常的慢性且严重的精神疾病,在全球范围内影响着超过2000万人,患者早年死亡率相较普通人可能高出2-3倍。

Infection:戊型肝炎病毒感染与精神分裂症的发生之间没有相关性

戊型肝炎多数病例症状较轻,黄疸不很严重。治疗 适当休息、合理营养为主,选择性使用药物为辅。

拓展阅读

Schizophrenia: 精神分裂症或首次发作精神病的表观遗传年龄加速和GrimAge成分的Meta分析

精神分裂症患者和首次发作精神病患者的表观遗传年龄加速显著高于对照组,尤其在GrimAge、DunedinPACE及其相关蛋白质预测值(如腺苷髓素、胱抑素C)中显现显著差异。

Schizophrenia:沙诺美林与氯托斯品治疗精神分裂症的疗效:三项5周随机双盲对照试验的汇总结果

KarXT在改善精神分裂症状方面表现出显著的疗效,其对正负症状的改善效果较安慰剂显著,且适用于不同人口特征的患者。

Schizophrenia:跨精神分裂症谱系和重度抑郁障碍与脑结构的关联

研究发现句法多样性与右侧中央前后回和上纵束的灰质及白质微结构正相关,而句法复杂性在不同诊断组中的结构关联存在差异。整体结果显示,精神分裂症谱系和重度抑郁障碍患者在句法生成的神经结构基础上有重叠和差异。

临床总结:精神分裂症患者的麻醉管理

本文介绍精神疾病概况及精神分裂症相关内容,包括抗精神分裂症药物分类,阐述精神分裂症患者麻醉管理要点,强调围术期个体化准备和管理的重要性。

Schizophrenia:首发精神病患者中超重与认知表现的性别差异

超重对首发精神病患者的认知表现存在显著的性别差异,超重女性在处理速度、言语学习与记忆、推理与问题解决能力等方面表现较差,而男性则未表现出类似差异。

Molecular Psychiatry:自由观看中的凝视行为揭示了四种主要精神疾病中视觉显著性处理的差异——1012人的巨型分析研究

精神分裂症患者的视觉显著性处理异常与幻觉、妄想等精神病性症状的严重程度相关,而其他精神疾病患者则表现出不同程度的显著性处理异常。